“…Several studies have suggested that immunochemical FOBT (I-FOBT) is more sensitive and specific than G-FOBT Saito et al, 2000;Zappa et al, 2001; Levi et al, 2006;Guittet et al, 2007), requiring no dietary restrictions, and might substantially improve screening cost effectiveness Saito et al, 2000). Further progress in I-FOBT use was made by the introduction of the latex agglutination test (LAT), a quantitative and fully automated test (Yamamoto et al, 1990), which made it possible to choose the positivity cutoff values to optimise the balance between sensitivity and specificity, though the debate about the optimal cutoff point continues (Itoh et al, 1996;Castiglione et al, 2000;Nakama et al, 2001;Edwards, 2005;Vilkin et al, 2005). Sensitivity of G-FOBT and a previously used I-FOBT (reversed passive haemagglutination (RPHA)) for CRC, based on proportional interval cancer incidence, was determined previously (Zappa et al, 2001).…”